- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06295835
Method Comparison Study for Measuring Potassium (K) and Ionized Calcium (iCa) in Blood
March 17, 2025 updated by: Abbott Point of Care
Clinical Evaluation of the Potassium (K) and Ionized Calcium (iCa) Tests in Capillary Specimens Using the i-STAT CG8+ Cartridge With the i-STAT 1 Analyzer
Method comparison study for Potassium (K) and ionized calcium (iCa).
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
The objective of this study is to compare the performance of the K and iCa Tests using the IUO i-STAT CG8+ Cartridge on the i-STAT 1 Analyzer to the performance of the K and iCa Tests on the comparator device using capillary whole blood specimens.
This objective will be assessed as part of a Method Comparison evaluation.
Study Type
Interventional
Enrollment (Actual)
232
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Ottawa, Ontario, Canada, K2H 8V4
- Abbott Point of Care (APOC)
-
-
-
-
Maryland
-
Baltimore, Maryland, United States, 17033
- University of Maryland (UMD)
-
-
Pennsylvania
-
Hershey, Pennsylvania, United States, 17033
- Penn State University Hershey Medical Center (Hershey)
-
-
Washington
-
Redmond, Washington, United States, 98052
- Eastside Research Associates (ERA)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Signed and dated consent form (if required by the IRB)
- ≥ 18 years of age
Exclusion Criteria:
• Prior enrollment in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Method comparison for K and iCa Tests using capillary whole blood specimens.
Compare the performance of the K and iCa Tests using the IUO i-STAT CG8+ Cartridge on the i-STAT 1 Analyzer to the performance of the K and iCa Tests on the comparator device using capillary whole blood specimens collected from two separate fingersticks.
|
Capillary blood specimen collected from two separate fingersticks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Performance comparison
Time Frame: Up to 5 minutes
|
Compare the performance of the Potassium (K) test using the IUO i-STAT CG8+ Cartridge on the i-STAT 1 Analyzer to the performance of the K test on a comparator device.
|
Up to 5 minutes
|
|
Performance comparison
Time Frame: Up to 5 minutes
|
Compare the performance of the ionized calcium (iCa) test using the IUO i-STAT CG8+ Cartridge on the i-STAT 1 Analyzer to the performance of the iCa test on a comparator device.
|
Up to 5 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Manish Gupta, BS, MBA, Abbott Point of Care
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 31, 2024
Primary Completion (Actual)
January 29, 2025
Study Completion (Actual)
January 29, 2025
Study Registration Dates
First Submitted
February 26, 2024
First Submitted That Met QC Criteria
March 5, 2024
First Posted (Actual)
March 6, 2024
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 17, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- CS-2024-0001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood
-
Abbott Point of CareCompletedPrecision of Potassium (K) Test in Capillary Whole BloodUnited States, Canada
Clinical Trials on Fingerstick blood draw
-
Abbott Point of CareCompletedPrecision of Potassium (K) Test in Capillary Whole BloodUnited States, Canada
-
LumiraDx UK LimitedCompletedAnticoagulants and Bleeding DisordersGermany
-
LumiraDx UK LimitedRecruitingInfections | Inflammation | Embolism and Thrombosis | Cardiovascular | RenalUnited Kingdom
-
West Virginia UniversityNot yet recruitingHIV Testing | Syphilis | HEPATITIS C (HCV) | Hepatitis B Virus (HBV)United States
-
University Hospital, Strasbourg, FranceNot yet recruitingKidney Transplantation | Humoral Rejection | Kidney Allograft Biopsy | Microvascular Inflammation
-
Vanderbilt University Medical CenterEnrolling by invitationAcute Phase ResponseUnited States
-
Turtle Health, Inc.Completed
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted